Zehra Parlak
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$6.8MFederal grants as PI11 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
11 awards · $6.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 2, 2024 | NIH | SBIR Phase II High-throughput injectability screening of high concentration protein formulations by microfluidic quartz resonators | $887K | QATCH TECHNOLOGIES LLC |
| Aug 12, 2024 | NIH | SBIR Phase II High-throughput injectability screening of high concentration protein formulations by microfluidic quartz resonators | $45K | QATCH TECHNOLOGIES LLC |
| Sep 15, 2023 | NIH | SBIR Phase II High-throughput injectability screening of high concentration protein formulations by microfluidic quartz resonators | $951K | QATCH TECHNOLOGIES LLC |
| Aug 30, 2023 | NIH | SBIR Phase II High-throughput injectability screening of high concentration protein formulations by microfluidic quartz resonators | $951K | QATCH TECHNOLOGIES LLC |
| Jan 19, 2023 | NIH | SBIR Phase II Developing prototype injectability and developability testing system based on microfluidic quartz resonators | $901K | QATCH TECHNOLOGIES LLC |
| Feb 8, 2022 | NIH | SBIR Phase II Developing prototype injectability and developability testing system based on microfluidic quartz resonators | $599K | QATCH TECHNOLOGIES LLC |
| Feb 8, 2022 | NIH | SBIR Phase II Developing prototype injectability and developability testing system based on microfluidic quartz resonators | $1.5M | QATCH TECHNOLOGIES LLC |
| Aug 26, 2020 | NSF | SBIR Phase I SBIR Phase I: High-throughput injectability screening of high concentration protein formulations by multiplexed microfluidic quartz resonators | $256K | QATCH TECHNOLOGIES LLC |
| Aug 1, 2020 | NIH | SBIR Phase I Injectability analysis of high concentration protein formulations by extending shear-rate range in microfluidic quartz viscometers | $250K | QATCH TECHNOLOGIES LLC |
| Jul 27, 2020 | NIH | SBIR Phase I Injectability analysis of high concentration protein formulations by extending shear-rate range in microfluidic quartz viscometers | $250K | QATCH TECHNOLOGIES LLC |
| Jun 16, 2017 | NSF | STTR Phase I STTR Phase I: Microfluidic quartz resonator based blood plasma coagulation monitors | $225K | QATCH TECHNOLOGIES LLC |
Peer ranks
Federal funding#158
Awards as PI#114
Patents#505
Companies
- QATCH TECHNOLOGIES LLCLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.